ARTICLE | Company News
Protez, Sumitomo deal
May 23, 2005 7:00 AM UTC
Sumitomo granted an exclusive license to Protez to develop and commercialize SMP-601, a preclinical beta-lactam antibiotic, in North America and Europe. Sumitomo is eligible for milestones and royalti...